Selected to Succeed: How Run-In Phases Shape the Evidence Clinicians Inherit
Placebo run-ins and responder-enrichment designs can reduce trial noise, but they also change the question a study answers. When exclusion criteria are reported thinly, US clinicians may inherit effect estimates that apply to a narrower population than the label implies.